Coronary Artery Bypass Graft Market Regional Analysis:
North America Market Insights
North America industry is estimated to hold largest revenue share of 49.8% by 2034. The market growth is attributed to the rising prevalence of cardiovascular diseases, particularly CAD. In addition to the rising disease burden, the region benefits from advanced healthcare infrastructure, cutting-edge medical technologies, and a strong reimbursement system that makes CABG surgeries more accessible.
In the U.S., CVD remains the leading cause of death, which is contributing to the rise of CABG surgeries. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2022, approximately 1 in every 5 deaths from cardiovascular diseases (CVDs) occurred among persons under the age of 65. Furthermore, an aging population, lifestyle factors such as obesity and sedentary behavior, and an increase in associated comorbidities like diabetes are all accelerating the demand for cardiac interventions.
Canada boosts a well-developed healthcare system with significant investments in hospitals and specialized cardiac care centers. This infrastructure supports a high volume of CABG surgeries, particularly in larger hospitals equipped with advanced surgical tools and technologies.
APAC Market Insights
The coronary artery bypass graft market of Asia Pacific is poised to register the fastest revenue growth by 2034. APAC countries are investing heavily in healthcare improvements, expanding the reach of advanced treatment options, including CABG, especially in urban areas. This development is particularly notable in emerging coronary artery bypass graft markets like India and China.
In China, the government is actively investing in the healthcare sector, aiming to improve access to quality medical services. This includes providing better healthcare financing, insurance coverage, and reimbursement for surgeries like CABG, which makes these treatments more accessible to the broader population. China's National Health and Family Planning Commission intends to increase the size of the country's health service sector to approximately USD 2.4 trillion by 2030.
In India, the growing geriatric population is a significant factor, as older individuals are at a higher risk for CADs. This demographic shift is expected to continue fueling demand for CABG procedures in the coming years. According to the United Nations Population Fund (UNFPA), as of 2023, the elderly population in the country reached 153 million and is expected to reach 347 million by 2050.
